“#FierceMadness 2024: Best Biotech Name Tournament Round of 32 Results”

1. The #FierceMadness tournament, inspired by the NCAA championship, focuses on assessing distinctive drug names from new approvals in 2022 and 2023.
2. Fierce Pharma and its sister publication Fierce Biotech organized the Best Drug Name Tournament and the Best Biotech Company Name Madness respectively.
3. In the Round of 32 results for the Best Biotech Name Tournament, Mounjaro (for diabetes) defeated Daxxify, while AstraZeneca's Beyfortus (RSV medication) beat Pfizer's COVID treatment.
4. Ionis' rare disease therapy Wainua also advanced to the next round with a significant margin against another Pfizer asset.
5. Daybue won its matchup against Johnson & Johnson's myeloma med Talvey, progressing to the Final Four challengers.
6. The voting process was open until certain deadlines, with the final vote determining the championship winner.
7. Readers were encouraged to provide comments about their choices during voting, which would be considered in recaps throughout each round.